Loading insider details...
Latest Form 4 (Jun 11, 2026): Disposition to Issuer of 150,260 KALV shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | KalVista Pharmaceuticals, Inc. (KALV) | Disposition to Issuer | 150,260 | n/a |
| May 27, 2026 | KalVista Pharmaceuticals, Inc. (KALV) | Exercise/Conversion | 5,000 | n/a |
| May 26, 2026 | KalVista Pharmaceuticals, Inc. (KALV) | Exercise/Conversion | 6,250 | n/a |
| May 19, 2026 | KalVista Pharmaceuticals, Inc. (KALV) | Exercise/Conversion | 2,419 | n/a |
| Apr 20, 2026 | KalVista Pharmaceuticals, Inc. (KALV) | Exercise/Conversion | 6,250 | n/a |
| Feb 25, 2026 | KalVista Pharmaceuticals, Inc. (KALV) | Exercise/Conversion | 6,250 | n/a |
| Feb 20, 2026 | KalVista Pharmaceuticals, Inc. (KALV) | Exercise/Conversion | 2,419 | n/a |
| Jan 21, 2026 | KalVista Pharmaceuticals, Inc. (KALV) | Grant/Award | 100,000 | n/a |
| Nov 26, 2025 | KalVista Pharmaceuticals, Inc. (KALV) | Exercise/Conversion | 6,250 | n/a |
| Nov 19, 2025 | KalVista Pharmaceuticals, Inc. (KALV) | Exercise/Conversion | 6,447 | n/a |